Cancer· 2017Q1
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
- 970citations
- Q1SCImago
- 2017year
Short summary
The ProMisE classifier, using readily available immunohistochemistry and sequencing, accurately categorizes endometrial cancer (EC) into four prognostic subgroups with distinct survival outcomes, outperforming current ESMO risk stratification.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Obstetrics and Gynecology
Obstetrics and GynecologyMedicine